Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
As of: Nov 16, 2026 · 3:54 PM EST

Elite Pharmaceuticals (ELTP) Other Non-Current Assets (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Other Assets of $571,824 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 6.4% from $610,926 a year earlier but up 0.8% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Other Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Other Assets came in at $563,501, up 3.3% from FY2025.

  • Annual Other Assets has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 2.6% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Other Assets was $545,757 in FY2025 (+3.5%), $527,072 in FY2024 (+21.6%), $433,452 in FY2023 (-12.7%) and $496,777 in FY2022 (unchanged).
  • Quarterly Other Assets has run from a low of $405,164 in fiscal Q3 2023 to a high of $910,767 in fiscal Q3 2025 over five years.
  • On a year-over-year basis, Other Assets increased in six of the last eight quarters, with growth averaging 11.2%.
  • The strongest year-over-year quarter for Other Assets in the past five years was fiscal Q3 2025, with growth of 109.2%; the weakest was fiscal Q3 2023, with a decline of 47.4%.
  • According to Business Quant data, Other Assets for the three prior fiscal quarters was $567,422 (Q1 2027), $563,501 (Q4 2026) and $559,556 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 15.10 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.42 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 700.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.90 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 10.02 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 571,824.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 571,824.00
Jun 30, 2026 567,422.00
Mar 31, 2026 563,501.00
Dec 31, 2025 559,556.00
Sep 30, 2025 610,926.00
Jun 30, 2025 550,299.00
Mar 31, 2025 545,757.00
Dec 31, 2024 910,767.00
Sep 30, 2024 543,364.00
Jun 30, 2024 532,462.00
Mar 31, 2024 527,072.00
Dec 31, 2023 435,258.00
Sep 30, 2023 443,768.00
Jun 30, 2023 436,448.00
Mar 31, 2023 433,452.00
Dec 31, 2022 405,164.00
Sep 30, 2022 496,902.00
Jun 30, 2022 696,901.00
Mar 31, 2022 496,777.00
Dec 31, 2021 769,590.00
API Access

Elite Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ELTP&period=max&api_key=YOUR_API_KEY